Cure Quick Pharma Private Limited
About Cure Quick Pharma Private Limited
Data last updated:
Cure Quick Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC287272. Its GSTIN is 02AAGCC2494M1ZJ (Himachal Pradesh).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹38 Lakh. It is led by directors Siddharth and Harish Kumar Digani.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at House No. 38 Sfs Flats Block – Bu Pitampura, New, Delhi, India – 110034.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.52 Cr, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹52,984 (net margin -0.3%) and EBITDA of ₹3.27 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹8.8 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No. 38 Sfs Flats Block – Bu Pitampura, New, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cure Quick Pharma Private Limited
The main business activity of Cure Quick Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cure Quick Pharma Private Limited FY 2021 filings available
Cure Quick Pharma Private Limited reported revenue of ₹1.52 Cr (down 65% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Cure Quick Pharma Private Limited
Revenue fell 65% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cure Quick Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹1.52 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.27 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹52,984 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cure Quick Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cure Quick Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cure Quick Pharma Private Limited
Cure Quick Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leelabco Remedies Private Limited | •••• | •••• | •••• | •••• | - | Noida, Uttar Pradesh, India |
| Lalith Pharma-Marketing Private Limited | •••• | •••• | •••• | •••• | - | Banagalore, Karnataka, India |
| Shree Vishwamitra Ayurved Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Afd Laboratories Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Skydew Pharmaceutical Private Limited | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Cure Quick Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Wytech Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Sahana Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 12 | Nagercoil, Tamil Nadu, India |
| Aaryan Biocare Products Private Limited | •••• | •••• | •••• | •••• | - | Pune, Maharashtra, India |
| Bharat Remedies Pvt Ltd | •••• | •••• | •••• | •••• | - | Punjab, India |
| Inizia Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Cure Quick Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Cure Quick Pharma Private Limited
Cure Quick Pharma Private Limited is audited by GROVER DINESH & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GROVER DINESH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cure Quick Pharma Private Limited
Cure Quick Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Also directs: Cure Quick Remedies Private Limited | Director | 18 Jan 2024 | 2 Years 8 Months | Current |
| Harish Kumar Digani Also directs: Cure Quick Remedies Private Limited | Director | 09 Nov 2015 | 10 Years 10 Months | Current |
Ownership and Shareholding of Cure Quick Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cure Quick Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2020 | State Bank of India | ₹8.8 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Cure Quick Pharma Private Limited
Cure Quick Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Civil suit | Filed against the company by Shilex Chemicals Private Limited | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by Medisys Biotech Private Limited | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Cure Quick Pharma Private Limited
Employment history and EPFO contributions of people linked to Cure Quick Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cure Quick Pharma Private Limited
Cure Quick Pharma Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Rajesh Kumar ceased to be Director on 19 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Cure Quick Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cure Quick Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cure Quick Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cure Quick Pharma Private Limited
Cure Quick Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAGCC2494M1ZJ | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cure Quick Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cure Quick Pharma Private Limited
Cure Quick Pharma is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 November 2015 (11+ years old) and is registered under CIN U24100DL2015PTC287272.
Cure Quick Pharma reported revenue of ₹1.52 Cr for FY 2021 (down 65% YoY).
Cure Quick Pharma has 2 current directors:
- Siddharth - Director
- Harish Kumar Digani - Director
Cure Quick Pharma reported a net loss of ₹52,984 (net margin -0.3%) and EBITDA of ₹3.27 Lakh (EBITDA margin 2.1%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cure Quick Pharma is -39% over three years and 15% over five years. In the latest year (FY 2021) revenue fell 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cure Quick Pharma is 02AAGCC2494M1ZJ, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Cure Quick Pharma is U24100DL2015PTC287272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cure Quick Pharma has 2 court cases on record: 2 filed against it.
Cure Quick Pharma was incorporated on 09 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cure Quick Pharma by revenue are Leelabco Remedies Private Limited, Lalith Pharma-Marketing Private Limited, Shree Vishwamitra Ayurved Pharmaceuticals Private Limited, Afd Laboratories Private Limited, Skydew Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations).
Rajesh Kumar ceased to be Director on 19 Jan 2024. Siddharth was appointed as Director on 18 Jan 2024. Harish Kumar Digani was appointed as Director on 09 Nov 2015.